Contents

Article Outline

• Chapter 1
• Chapter 2
• Chapter 3
• Chapter 4
• Chapter 5

Preface: Acute and chronic venous disease. Current status and future directions 1S

Mark H. Meissner, MD, Bo Eklof, MD, PhD, Joann M. Lohr, MD, Fedor Lurie, MD, PhD, Robert Kistner, MD, and Thomas W. Wakefield, MD, Seattle, Wash; Helsingborg, Sweden; Cincinnati, Ohio; Honolulu, Hawaii; and Ann Arbor, Mich

Back to Article Outline

Chapter 1 

The hemodynamics and diagnosis of venous disease 4S

Mark H. Meissner, MD, Gregory Moneta, MD, Kevin Bernard, MD, Peter Gloviczki, MD, Joann M. Lohr, MD, Fedor Lurie, MD, Mark A. Mattos, MD, Robert B. McLafferty, MD, Geza Mozes, MD, Robert B. Rutherford, MD, Frank Padberg, MD, and David S. Sumner, MD, Seattle, Wash; Portland, Ore; London, United Kingdom; Rochester, Minn; Cincinnati, Ohio; Honolulu, Hawaii; Seattle, Wash; Springfield Ill; Corpus Christi, Tex; and Newark, NJ

Back to Article Outline

Chapter 2 

Acute venous disease: Venous thrombosis and venous trauma 25S

Mark H. Meissner, MD, Thomas W. Wakefield, MD, Enrico Ascher, MD, Joseph A. Caprini, MD, Anthony J. Comerota, MD, Bo Eklof, MD, PhD, David L. Gillespie, MD, Lazar J. Greenfield, MD, Aiwu Ruth He, MD, Peter K. Henke, MD, Anil Hingorani, MD, Russell D. Hull, MD, Craig M. Kessler, MD, Robert D. McBane, MD, and Robert McLafferty, MD, Seattle, Wash; Ann Arbor, Mich; Brooklyn, NY; Evanston and Springfield, Ill; Toledo, Ohio; Helsingborg, Sweden; Potomac, Md; Ann Arbor, Mich; Washington DC; Calgary Canada; and Rochester, Minn

Back to Article Outline

Chapter 3 

Primary chronic venous disorders 54S

Mark H. Meissner, MD, Peter Gloviczki, MD, John Bergan, MD, Robert L. Kistner, MD, Nick Morrison, MD, Felizitas Pannier, MD, Peter J. Pappas, MD, Eberhard Rabe, MD, Seshadri Raju, MD, and J. Leonel Villavicencio, MD, Seattle, Wash; Rochester, Minn; La Jolla, Calif; Honolulu, Hawaii; Scottsdale Ariz; Bonn, Germany; Newark, NJ; Jackson, Miss; and Bethesda, Md

Back to Article Outline

Chapter 4 

Secondary chronic venous disorders 68S

Mark H. Meissner, MD, Bo Eklof, MD, Phillip Coleridge Smith, MD, Michael C. Dalsing, MD, Ralph G. DePalma, MD, Peter Gloviczki, MD, Gregory Moneta, MD, Peter Neglén, MD, Thomas O’ Donnell, MD, Hugo Partsch, MD, and Seshadri Raju, MD, Seattle, Wash; Helsingborg, Sweden; London, United Kingdom; Indianapolis, Ind; Washington DC; Rochester, Minn; Portland, Ore; Flowood and Jackson, Miss; Boston, Mass; and Vienna, Austria

Back to Article Outline

Chapter 5 

Mapping the future: Organizational, clinical, and research priorities in venous disease 84S

Mark H. Meissner, MD, Bo Eklof, MD, Peter Gloviczki, MD, Joann M. Lohr, MD, Fedor Lurie, MD, Robert Kistner, MD, Gregory Moneta, MD, and Thomas W. Wakefield, MD, Seattle, Wash; Helsingborg, Sweden; Rochester, Minn; Cincinnati, Ohio; Honolulu, Hawaii; Portland, Ore; and Ann Arbor, Mich